192 related articles for article (PubMed ID: 19327103)
1. Dipeptidyl peptidases and related proteins: multifaceted markers and therapeutic targets.
De Meester I; Scharpé S; Lambeir AM
Clin Chem Lab Med; 2009; 47(3):245-7. PubMed ID: 19327103
[No Abstract] [Full Text] [Related]
2. Structure and function in dipeptidyl peptidase IV and related proteins.
Gorrell MD; Wang XM; Park J; Ajami K; Yu DM; Knott H; Seth D; McCaughan GW
Adv Exp Med Biol; 2006; 575():45-54. PubMed ID: 16700507
[No Abstract] [Full Text] [Related]
3. Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4.
Lin K; Cai Z; Wang F; Zhang W; Zhou W
Chem Pharm Bull (Tokyo); 2013; 61(4):477-82. PubMed ID: 23358258
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological Implications of Dipeptidyl Peptidases.
Sato A; Ogita H
Curr Protein Pept Sci; 2017; 18(8):843-849. PubMed ID: 28356045
[TBL] [Abstract][Full Text] [Related]
5. Post-proline-cleaving peptidases having DP IV like enzyme activity. Post-proline peptidases.
Abbott CA; Yu D; McCaughan GW; Gorrell MD
Adv Exp Med Biol; 2000; 477():103-9. PubMed ID: 10849735
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
7. [Peptidases of oral Streptococci--II. Purification and characterization of dipeptidyl peptidase IV from Streptococcus salivarius HHT].
Mineyama R; Saito K
Shigaku; 1986 Dec; 74(5):1056-71. PubMed ID: 2881239
[No Abstract] [Full Text] [Related]
8. Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.
Bjelke JR; Christensen J; Nielsen PF; Branner S; Kanstrup AB; Wagtmann N; Rasmussen HB
Biochem J; 2006 Jun; 396(2):391-9. PubMed ID: 16475979
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization.
Zeng S; Xie H; Zeng LL; Lu X; Zhao X; Zhang GC; Tu ZC; Xu HJ; Yang L; Zhang XQ; Hu W
Bioorg Med Chem; 2013 Apr; 21(7):1749-55. PubMed ID: 23434133
[TBL] [Abstract][Full Text] [Related]
10. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
Deng J; Peng L; Zhang G; Lan X; Li C; Chen F; Zhou Y; Lin Z; Chen L; Dai R; Xu H; Yang L; Zhang X; Hu W
Eur J Med Chem; 2011 Jan; 46(1):71-6. PubMed ID: 21106276
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase (DP) 6 and DP10: novel brain proteins implicated in human health and disease.
McNicholas K; Chen T; Abbott CA
Clin Chem Lab Med; 2009; 47(3):262-7. PubMed ID: 19676137
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibitor with β-amino amide scaffold: synthesis, SAR and biological evaluation.
Kim HJ; Kwak WY; Min JP; Sung SY; Kim HD; Kim MK; Kim HS; Park KJ; Son MH; Kim SH; Lee BJ
Bioorg Med Chem Lett; 2012 Sep; 22(17):5545-9. PubMed ID: 22850208
[TBL] [Abstract][Full Text] [Related]
13. Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: a new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554.
Banno Y; Miyamoto Y; Sasaki M; Oi S; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Tsubotani S; Tani A; Funami M; Tawada M; Yamamoto Y; Aertgeerts K; Yano J; Maezaki H
Bioorg Med Chem; 2011 Aug; 19(16):4953-70. PubMed ID: 21764322
[TBL] [Abstract][Full Text] [Related]
14. Prediction of dipeptidyl peptidase (DP) 8 structure by homology modelling.
Pitman MR; Menz RI; Abbott CA
Adv Exp Med Biol; 2006; 575():33-42. PubMed ID: 16700506
[No Abstract] [Full Text] [Related]
15. Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype rats.
Retlich S; Withopf B; Greischel A; Staab A; Jaehde U; Fuchs H
Biopharm Drug Dispos; 2009 Nov; 30(8):422-36. PubMed ID: 19771584
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
[TBL] [Abstract][Full Text] [Related]
17. Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.
Matheeussen V; Baerts L; De Meyer G; De Keulenaer G; Van der Veken P; Augustyns K; Dubois V; Scharpé S; De Meester I
Biol Chem; 2011 Mar; 392(3):189-98. PubMed ID: 21194356
[TBL] [Abstract][Full Text] [Related]
18. Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
Driessen JHM; Knapen LM; Geusens PPMM; van den Bergh JPW
Osteoporos Int; 2017 Aug; 28(8):2429-2430. PubMed ID: 28707090
[No Abstract] [Full Text] [Related]
19. Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis.
Yu DM; Wang XM; McCaughan GW; Gorrell MD
FEBS J; 2006 Jun; 273(11):2447-60. PubMed ID: 16704418
[TBL] [Abstract][Full Text] [Related]
20. Glycemia Lowering and Risk for Heart Failure: Recent Evidence from Studies of Dipeptidyl Peptidase Inhibition.
Zhong J; Goud A; Rajagopalan S
Circ Heart Fail; 2015 Jul; 8(4):819-25. PubMed ID: 26199308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
